USANA Health Sciences (NYSE:USNA) Sheds US$51m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
Personal Care Stocks Q4 Teardown: USANA (NYSE:USNA) Vs The Rest
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
At US$27.31, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?
U.S. Egg Prices Halve Since January Peak, White House Notes
USANA Health Sciences Faces Market Risk With Uncertain Hiya Acquisition Benefits
Usana Health Sciences | 10-K: FY2024 Annual Report
Insider Sale: Director at $USNA Sells 780 Shares
USANA Exec. Chairman Kevin Guest Invites All to Celebrate March's Listening Awareness Month
USANA Health Sciences Earnings Call Highlights Growth and Strategic Moves
USANA Health Sciences Stock Tumbles Following Tepid FY2025 Guidance
USANA Health Sciences Is Maintained at Neutral by DA Davidson
Usana Health Sciences Analyst Ratings
USANA Health Sciences Down Nearly 14%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk
D.A. Davidson Maintains Usana Health Sciences(USNA.US) With Hold Rating, Cuts Target Price to $36
Earnings Call Summary | Usana Health Sciences(USNA.US) Q4 2024 Earnings Conference
USANA Health Sciences Q4 24 Earnings Conference Call At 11:00 AM ET
Usana Health Sciences Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results.
USANA Health Sciences Non-GAAP EPS of $0.64 Beats by $0.15, Revenue of $214M Beats by $5.18M